Raspberry Pi has revealed the Pi 500+, an upgraded version of its keyboard PC that builds on the foundation of last year's Pi 500. The new model is made for people who use the Raspberry Pi as their ...

Discover Easy, Affordable, and Reliable PCB manufacturing with JLCPCB! #RaspberryPi #VirtualPet #PCBMaking #JLCPCB #DIYElectronics #RaspberryPiProjects #ElectronicsDIY #PCBManufacturing #TechProjects ...

Excel is the world’s most versatile data modeling tool—powering everything from household budgets to Fortune 500 profit and loss statements (P&Ls). Yet, the full power of Excel is available only to ...

The Raspberry Pi 500 Plus is available now with a $110 price bump over last year’s model. The Raspberry Pi 500 Plus is available now with a $110 price bump over last year’s model. is a senior ...

The Raspberry Pi 500 (and 400) systems are versions of the Raspberry Pi built for people who use the Raspberry Pi as a general-purpose computer rather than a hobbyist appliance. Now the company is ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...

When Raspberry Pi released the Pi 500, as essentially an RPi 5 integrated into a chiclet keyboard, there were rumors based on the empty spots on the PCB that a better version would be released soon.

The Raspberry Pi 500+ is arriving for $200, and offers more RAM and storage than the regular 500 model. It also adopts mechanical key switches instead of membrane keys. Raspberry Pi is launching a new ...

How fitting that Raspberry Pi Foundation chose a throwback Thursday to unveil its Raspberry Pi 500+, an all-in-one PC that gives off some serious Commodore 64 vibes. Or as the Foundation puts it, the ...

With today’s rollout of developer betas for iOS 26.1, iPadOS 26.1, and macOS Tahoe 26.1, Apple began to lay the groundwork for adopting Anthropic’s protocol for agentic AI. Here’s what this means. MCP ...

Pfizer is doubling down on obesity treatments by spending $4.9 billion on the development-stage drugmaker Metsera. The COVID-19 vaccine and treatment maker said early Monday that it will pay $47.50 ...